loader
Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing Deferasirox in Europe. Original Data : EMA Website

Menu
$ API Ref.Price (USD/KG) : 408Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3ABDI FARMA GMBH

02 3ACCORD HEALTHCARE SLU

03 3AUROBINDO PHARMA ITALIA SRL

04 6Accord Healthcare AG

05 3DOC GENERICI SRL

06 3MYLAN PHARMACEUTICALS LIMITED

07 6Mepha Pharma AG

08 3NOVARTIS EUROPHARM LTD

09 6Novartis Pharma Schweiz AG

10 3SANDOZ SPA

11 3Torrent Pharma, Inc.

12 1World Medicine Ilac San ve tic LTD STl

13 3ZENTIVA ITALIA SRL

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Deferasirox

Brand Name : DEFERASIROX ABDI

Dosage Form : Film-Coated Tablets

Dosage Strength : 180 mg

Packaging : 30 UNITS 180 MG - RAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

02

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Deferasirox

Brand Name : DEFERASIROX ABDI

Dosage Form : Film-Coated Tablets

Dosage Strength : 360 mg

Packaging : 30 UNITS 360 MG - RAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

03

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Deferasirox

Brand Name : DEFERASIROX ABDI

Dosage Form : Film-Coated Tablets

Dosage Strength : 90 mg

Packaging : 30 UNITS 90 MG - RAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

04

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Deferasirox

Brand Name : DEFERASIROX ACCORD

Dosage Form : Film-Coated Tablet Oral Use Blister

Dosage Strength : 180 mg

Packaging : 30 UNITS 180 MG - RAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Deferasirox

Brand Name : DEFERASIROX ACCORD

Dosage Form : Film-Coated Tablet Oral Use Blister

Dosage Strength : 360 mg

Packaging : 30 UNITS 360 MG - RAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Deferasirox

Brand Name : DEFERASIROX ACCORD

Dosage Form : Film-Coated Tablet

Dosage Strength : 90mg

Packaging : 30 UNITS 90 MG - RAL USE

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Deferasirox

Brand Name :

Dosage Form : TABLET

Dosage Strength : 125MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : United Kingdom

blank

08

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Deferasirox

Brand Name :

Dosage Form : TABLET

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : United Kingdom

blank

09

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Deferasirox

Brand Name :

Dosage Form : TABLET

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : United Kingdom

blank

10

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

Deferasirox

Brand Name :

Dosage Form : DISPERSIBLE TABLET

Dosage Strength : 125|250|500MG|MG|MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Turkey

blank